Grifols GRFS
NASDAQ GRFS
$8.62 -0.14 (-1.60%)
As of: Nov 11, 2026 · 10:06 AM EST

Grifols (GRFS) Capital Leases (2015 - 2016)

Updated

Grifols' Capital Leases came in at $7.09 million for the quarter ended Mar 31, 2016, up 10.8% from the prior quarter.

Analysis

Grifols (GRFS) Capital Leases (2015 - 2016) Analysis & Trends

As of Dec 31, 2015, Grifols' Capital Leases was $6.4 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Grifols 5.96 Bn 5.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 7.09 Mn
Dec 31, 2015 6.40 Mn
API Access

Grifols Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=GRFS&period=max&api_key=YOUR_API_KEY